SWOG clinical trial number
SWOG-8834

A Phase II Evaluation of Fazarabine in Central Nervous System Tumors

Closed
Phase
Accrual
45%
Published
Abbreviated Title
Fazarabine in CNS Tumors
Activated
07/01/1990
Closed
12/01/1991

Research committees

Brain Cancer

Treatment

Fazarabine

Publication Information Expand/Collapse

1994

A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study

GB Selby;C Upchurch;J Townsend;HJ Eyre Cancer Chemotherapy and Pharmacology 34(2):179-180